GSK Announces Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia
AMS signs agreement with TELA Bio, Inc. to commercialise LiquiBand Fix8® in the US under the brand name LIQUIFIXâ„¢
CQS New City High Yield Fund Ltd Annual Financial Report
North-Atlantic Smaller Companies Inv Tst Half-Year Report 2023
LondonMetric Property plc Sell Portfolio of Four Multi-Let Industrial Units
Hilton Foods and Walmart Canada Agreement
MJ Gleeson- Audited Results for Year Ended 30th June 2023
